Clin2
NCT07606664Possibly a fitNot yet recruiting

Study of a hot flash medication and its effects on heart and brain health

Menopause Hot Flashes

Treatments studied

Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.

This study tests a medication called fezolinetant to see if it helps with hot flashes and also looks at its effects on blood vessels and the brain. It is for women who are going through menopause and having frequent moderate to severe hot flashes.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
220 people
Ages
40 years to 65 years
Study type
Interventional

Who can take part

  • You were born female and are between 40 and 65 years old.
  • You have moderate to severe hot flashes (at least 7-8 per day or 50-60 per week) and are seeking treatment for them.
  • You are in menopause, meaning your periods have stopped for at least 6 months (with certain hormone levels) or 12 months, whichever applies.
  • Your body mass index (BMI) is between 18 and 38.
  • You agree not to participate in any other research studies while in this one.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06975111Recruiting· Phase 2/Phase 3
Improving health during menopause

This trial studies ways to help women during the late menopausal transition. It uses a smartphone app and telehealth visits to track your health and help you feel better.

Aurora, Colorado
NCT07602530Recruiting
Tracking Hot Flash Treatment Outcomes in Canadian Women

This study follows women in Canada who are starting fezolinetant, a new medication for hot flashes during menopause. Researchers will track how well it works and how you feel while using it in your regular doctor's care.

Montreal
NCT07829653Not yet recruiting· Phase 3
Hot flash relief for Indian women in menopause

This study tests a non-hormonal pill called fezolinetant to see if it reduces hot flashes in Indian women going through menopause. It may offer a new option for women who cannot or prefer not to use hormone therapy.

NCT07077395Recruiting· Phase 2
Hot flash study to check heart health links

This study looks at how hot flashes in midlife women might be connected to heart disease risk. Researchers want to see if managing hot flashes can improve heart health.

Boston, Massachusetts
NCT06957691Recruiting· Phase 2
Fezolinetant for hot flashes in men on hormone therapy

This study tests a medication called fezolinetant to see if it reduces hot flashes in men undergoing hormone therapy for prostate cancer. If you experience frequent hot flashes, this treatment might help alleviate them.

Boston, Massachusetts
NCT07033013Recruiting
Study of an oral supplement for menopause hot flashes

This study tests an oral product to see if it can help with menopause symptoms like hot flashes. It is for women aged 40–65 who still have a uterus and are not on hormone therapy.

San Francisco, California

Hear when a new Menopause Hot Flashes trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.